CN110604867A - Ultrasonic intermediate frequency medicine guide instrument - Google Patents
Ultrasonic intermediate frequency medicine guide instrument Download PDFInfo
- Publication number
- CN110604867A CN110604867A CN201810618640.7A CN201810618640A CN110604867A CN 110604867 A CN110604867 A CN 110604867A CN 201810618640 A CN201810618640 A CN 201810618640A CN 110604867 A CN110604867 A CN 110604867A
- Authority
- CN
- China
- Prior art keywords
- signal
- capacitor
- module
- medicine
- resistor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 212
- 238000006243 chemical reaction Methods 0.000 claims abstract description 73
- 229940079593 drug Drugs 0.000 claims abstract description 72
- 239000003990 capacitor Substances 0.000 claims description 65
- 238000012377 drug delivery Methods 0.000 claims description 33
- 239000011148 porous material Substances 0.000 claims description 21
- 238000004520 electroporation Methods 0.000 claims description 9
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 claims description 4
- 238000011282 treatment Methods 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 23
- 238000000554 physical therapy Methods 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 31
- 238000010586 diagram Methods 0.000 description 16
- 230000003287 optical effect Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 5
- 101000908580 Homo sapiens Spliceosome RNA helicase DDX39B Proteins 0.000 description 4
- 102100021298 b(0,+)-type amino acid transporter 1 Human genes 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102100039435 C-X-C motif chemokine 17 Human genes 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 101710155594 Coiled-coil domain-containing protein 115 Proteins 0.000 description 1
- 102100035027 Cytosolic carboxypeptidase 1 Human genes 0.000 description 1
- 102100025721 Cytosolic carboxypeptidase 2 Human genes 0.000 description 1
- 102100028043 Fibroblast growth factor 3 Human genes 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 description 1
- 101000932634 Homo sapiens Cytosolic carboxypeptidase 2 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100024061 Integrator complex subunit 1 Human genes 0.000 description 1
- 101710092857 Integrator complex subunit 1 Proteins 0.000 description 1
- 108050002021 Integrator complex subunit 2 Proteins 0.000 description 1
- 101710092886 Integrator complex subunit 3 Proteins 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 101001033011 Mus musculus Granzyme C Proteins 0.000 description 1
- 102100025254 Neurogenic locus notch homolog protein 4 Human genes 0.000 description 1
- 101100225046 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ecl2 gene Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
The invention belongs to the technical field of medical instruments, and provides an ultrasonic intermediate frequency medicine guide instrument; the method comprises the following steps: a remote controller configured to acquire a key signal of a user; the singlechip module is connected with the remote controller and generates a control signal according to the key signal; the signal conversion module is connected with the single chip microcomputer module and is configured to generate at least one of a first medicine guide signal, a second medicine guide signal and a third medicine guide signal according to the control signal; the electrode tip is connected with the signal conversion module and is configured to conduct ultrasonic medicine guiding according to the first medicine guiding signal, conduct electric pore-forming medicine guiding according to the second medicine guiding signal and conduct medium-frequency electric pulse medicine guiding according to the third medicine guiding signal. The invention can effectively solve the problem that the medicine guide instrument in the traditional technology lacks physical auxiliary means to promote the skin of a user to absorb medicines, and further the medicine guide instrument has poor treatment effect on the physical therapy part of the human body.
Description
Technical Field
The invention belongs to the technical field of medical instruments, and particularly relates to an ultrasonic intermediate frequency medicine guide instrument.
Background
With the increasing importance of people on their health, the frequency of using medical equipment by people is higher and higher; the medicine guide instrument is used as a medical device and can transfer the medicine to the skin of a human body, so that the medicine achieves a better treatment effect; compared with a method for manually smearing the medicine on the skin of a human body, the mode of transmitting the medicine to the skin through the medicine guide instrument can ensure the cleanliness of the medicine, prevent bacteria from infecting wounds and be simple and convenient to operate; but also can enable the medicine to exert better efficacy and accelerate the health recovery of the wound of the patient; due to the advantages of the medicine guide instrument, the medicine guide instrument is widely applied to various fields such as postoperative rehabilitation, chronic disease treatment, various inflammation treatments and the like.
However, the traditional medicine guide instrument simply and uniformly coats the medicine on the skin of the treatment part of the human body, for example, the medicine is coated on the skin of the cervical vertebra, the medicine guide instrument does not have any other physical auxiliary means to promote the skin of the human body to absorb the medicine, and the medicine cannot exert the best effect; and then the therapeutic effect of the medicine guide instrument on the part of the human body subjected to physical therapy in the traditional technology can not reach the expected effect, a large amount of medicines can be wasted, and the use experience of the user is reduced.
Disclosure of Invention
The invention provides an ultrasonic intermediate frequency medicine guide instrument, and aims to solve the problems that a medicine guide instrument in the traditional technology lacks a physical auxiliary means to promote the skin of a user to absorb medicines, so that the medicine guide instrument has poor treatment effect on a physical therapy part of a human body, and the use experience of the user is low.
The invention provides an ultrasonic intermediate frequency medicine guide instrument, which comprises:
a remote controller configured to acquire a key signal of a user;
the singlechip module is connected with the remote controller and generates a control signal according to the key signal;
the signal conversion module is connected with the single chip microcomputer module and is configured to generate at least one of a first medicine guide signal, a second medicine guide signal and a third medicine guide signal according to the control signal;
the electrode tip is connected with the signal conversion module and is configured to conduct ultrasonic medicine guiding according to the first medicine guiding signal, conduct electric pore-forming medicine guiding according to the second medicine guiding signal and conduct medium-frequency electric pulse medicine guiding according to the third medicine guiding signal.
In the ultrasonic intermediate frequency medicine guide instrument, a key signal of a user can be acquired through a remote controller, the signal conversion module can generate at least one of a first medicine guide signal, a second medicine guide signal and a third medicine guide signal according to a control signal, ultrasonic medicine guide, electric hole medicine guide and intermediate frequency electric pulse medicine guide can be carried out through the three medicine guide signals, when the ultrasonic intermediate frequency medicine guide instrument coats the medicine on a physical therapy part of a human body, the absorption of the human skin to the medicine is accelerated through three physical auxiliary means of ultrasonic waves, electric holes and intermediate frequency electric pulses, so that the medicine can exert the maximum treatment effect and the rapid healing of human diseases is accelerated; therefore, the ultrasonic intermediate frequency medicine guide instrument combines three physical auxiliary means to enable the medicine to exert the best effect on the part of the human body subjected to physical therapy, and improves the use experience of a user; therefore, the problems that the medicine guide instrument in the traditional technology lacks physical auxiliary means to promote the skin of a user to absorb medicines, so that the medicine guide instrument has poor treatment effect on the part of the human body subjected to physical therapy and the use experience of the user is low are solved.
Drawings
In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings needed to be used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings based on these drawings without creative efforts.
Fig. 1 is a block diagram of an ultrasonic intermediate frequency medicine guide instrument according to an embodiment of the present invention;
fig. 2 is a circuit configuration diagram of an ultrasonic wave generation module according to an embodiment of the present invention;
FIG. 3 is a block diagram of an electrical pore generation module according to an embodiment of the present invention;
fig. 4 is a circuit structure diagram of a first voltage converting unit according to an embodiment of the present invention;
fig. 5 is a circuit structure diagram of a second voltage converting unit according to an embodiment of the present invention;
fig. 6 is a circuit structure diagram of a third voltage converting unit according to an embodiment of the present invention;
fig. 7 is a circuit structure diagram of a fourth voltage converting unit according to an embodiment of the present invention;
fig. 8 is a circuit structure diagram of an intermediate frequency electric pulse generating module according to an embodiment of the present invention;
fig. 9 is a block diagram of an intermediate-frequency electric pulse generating module according to an embodiment of the present invention;
FIG. 10 is a block diagram of another ultrasonic mid-frequency drug delivery instrument provided in an embodiment of the present invention;
FIG. 11 is a circuit block diagram of an optical alarm module according to an embodiment of the present invention;
fig. 12 is a circuit structure diagram of an electric quantity detecting module according to an embodiment of the present invention;
fig. 13 is a circuit structure diagram of a first prompt module according to an embodiment of the present invention;
FIG. 14 is a circuit diagram of a second hinting module according to an embodiment of the invention;
fig. 15 is a circuit structure diagram of a single chip module according to an embodiment of the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
It should be noted that, according to the basic common knowledge of biology, the absorption of drugs by human skin is mainly through the epidermal stratum corneum to access the dermis, then spreading to the capillaries, and finally transferring to the systemic circulation; therefore, the more components in the drug permeate into the body through the skin, the greater the efficacy of the drug in the human body, and the more drug components absorbed by the human body; however, the skin of the human body has a certain saturation for absorbing liquid according to the cellular structure of the skin of the human body, and when the skin of the human body absorbs liquid to reach the certain saturation, the skin of the human body cannot absorb excessive medicine components, and the treatment effect of the medicine on the human body is reduced.
According to the microstructure of human skin, the ability of human skin to absorb drugs can be kept in a constant state without external interference; if some physical stimulation, such as electrical stimulation, ultrasonic stimulation and electric pulse stimulation, is applied to the skin of the human body, the absorption capacity of the skin of the human body to the medicine components is greatly increased; under the same conditions, external physical stimulation can greatly promote the blood circulation of the human body and improve venous blood backflow, so that the medicine can more quickly pass through the skin and enter the human body, and further a better treatment effect is exerted; therefore, the invention provides the ultrasonic intermediate-frequency medicine guide instrument which can realize three functions of ultrasonic medicine guide, electric pore-forming medicine guide and electric pulse medicine guide, and when a user uses the ultrasonic intermediate-frequency medicine guide instrument, the skin of a part to be treated of the user can absorb more medicine components, so that the ultrasonic intermediate-frequency medicine guide instrument has a better physical therapy effect on diseases of a human body, and the health of the user is greatly maintained.
Fig. 1 shows a module structure of an ultrasonic intermediate frequency drug guide apparatus 10 provided by an embodiment of the present invention, and for convenience of description, only the parts related to the embodiment of the present invention are shown, and detailed descriptions are as follows:
as shown in fig. 1, the ultrasonic intermediate frequency drug guide instrument 10 includes: the remote controller 20, the single chip microcomputer module 30, the signal conversion module 40 and the electrode tip 50; the remote controller 20 obtains a key signal D1 of the user, wherein the key signal D1 includes function selection information of the user; when the user uses the ultrasonic intermediate frequency drug guide instrument 10, different functions such as ultrasonic drug guide, electrical pore-forming drug guide and intermediate frequency electrical pulse drug guide can be selected through the key signal D1, so as to achieve the best treatment effect on different parts of the human body to be treated; the single chip microcomputer module 30 is connected with the remote controller 20, and the single chip microcomputer module 30 generates a control signal D2 according to the key signal D1; specifically, when the remote controller 20 transmits the key signal D1 to the single chip module 30, the single chip module 30 has a centralized processing and converting function on the signal, so that the single chip module 30 converts the key signal D1 to generate the control signal D2, and the control signal D2 can control each circuit module in the ultrasonic intermediate frequency drug guide apparatus 10 to be in a normal working state.
The signal conversion module 40 is connected with the single chip microcomputer module 30, the single chip microcomputer module 30 transmits the control signal D2 to the signal conversion module 40, and the signal conversion module 40 generates at least one of a first medicine guiding signal D3, a second medicine guiding signal D4 and a third medicine guiding signal D5 according to the control signal D2; the signal conversion module 40 may generate any one of three signals, i.e., a first drug-guiding signal D3, a second drug-guiding signal D4 and a third drug-guiding signal D5 according to the control signal D2, or generate any two or three of the three signals according to the control signal D2; because the user selects different drug delivery functions through the remote controller 20, the signal conversion module 40 can generate drug delivery signals (including the first drug delivery signal D3, the second drug delivery signal D4, and the third drug delivery signal D5) with different functions according to the control signal D2, and the ultrasound intermediate frequency drug delivery apparatus 10 can achieve different drug treatment effects according to the actual needs of the user.
The electrode tip 50 is connected to the signal conversion module 40, when a user selects different drug delivery functions in the remote controller, the signal conversion module 40 transmits a first drug delivery signal D3, a second drug delivery signal D4 and a third drug delivery signal D5 to the electrode tip 50, the electrode tip 50 conducts ultrasonic drug delivery according to the first drug delivery signal D3, the electrode tip 50 conducts electric pore-forming drug delivery according to the second drug delivery signal D4, and the electrode tip conducts medium-frequency electric pulse drug delivery according to the third drug delivery signal D5; specifically, in the ultrasonic medicine guiding, the frequency of ultrasonic wave is 800 kilohertz, when the part of human body receiving the ultrasonic wave is treated, the ultrasonic wave improves the venous and lymphatic return, and further promotes the medicine to be absorbed through skin or mucous membrane; in the electric pore-forming medicine guide, the current output by the electrode tip 50 is 5-20 milliamperes, and a user can adjust the current output by the electrode tip 50, so that the ultrasonic intermediate frequency medicine guide instrument can realize the optimal medicine guide effect of the electric head, wherein the micro current output by the electric drive can promote the blood circulation of a human body and reduce the pain feeling generated in the medicine feeding process of the user; in the medium-frequency electric pulse medicine guiding, the frequency of medium-frequency carrier waves is 3000 Hz, the modulation frequency is 10 Hz-150 Hz, the optimal medium-frequency electric pulse medicine guiding effect can be realized by adjusting the amplitude and the phase of the medium-frequency carrier waves, and the medium-frequency electric pulse medicine guiding device can play roles in softening scars, loosening adhesion and organizing hematoma on human bodies; in practical application, place the medicine in electrode tip 50, the user selects different functions and then electrode tip 50 carries out ultrasonic wave medicine guide, electric pore-creating medicine guide and intermediate frequency electric pulse medicine guide to the skin at human physiotherapy position, and then guarantees that skin can absorb more drug composition, and then realizes reaching the best treatment to the human body.
In the ultrasonic intermediate frequency drug delivery instrument 10, the electrode tip 50 can implement any one, any two or three of the three drug delivery modes (ultrasonic drug delivery, electric pore-forming drug delivery and intermediate frequency electric pulse drug delivery); for example, the electrode tip 50 conducts ultrasonic drug guiding and electric pore-forming drug guiding to the human body according to the first drug guiding signal D3 and the second drug guiding signal D4; for another example, the electrode tip 50 conducts medium-frequency electric pulse medicine guiding and the like to the human body according to the third medicine guiding signal D5; therefore, the user selects different medicine guiding functions through the remote controller 20, and then corresponding treatment is performed on different medicines and different parts to be treated, so that the best treatment effect on the parts to be treated by the human body is ensured through the ultrasonic intermediate frequency medicine guiding instrument 10, and the use experience of the user is improved.
As a preferred embodiment, the electrode head 50 includes a first electrode head 501 and a second electrode head 502; the treatment part of human body is received through two electrode heads and is led the medicine treatment, like cervical vertebra, shoulder, and then can adapt to human special body structure through two electrode heads, and human body is received and is treated the position and can contact electrode head 50 comprehensively, and then human skin can absorb more drug composition to improve the treatment of medicine to human body, bring good use comfort for the user.
In the embodiment of the present invention, the remote controller 20 may obtain a key signal D1 of the user, when the single-chip module 30 generates a control signal D2 according to the key signal D1, and the single-chip module 30 transmits the control signal D2 to the signal conversion module 40, the signal conversion module 40 may generate at least one of a first drug guiding signal D3, a second drug guiding signal D4, and a third drug guiding signal D5 according to the control signal D2, and the electrode tip 50 may respectively implement three drug guiding functions (ultrasonic drug guiding, electrical drug guiding, and intermediate-frequency electrical pulse drug guiding) according to the three drug guiding signals (the first drug guiding signal D3, the second drug guiding signal D4, and the third drug guiding signal D5); therefore, the ultrasonic medium-frequency drug delivery instrument 10 in the embodiment of the invention adopts three physical auxiliary means (ultrasonic waves, electric pore-forming and medium-frequency electric pulses) to promote the absorption capacity of human skin to drugs, so that the treated part of the human body can absorb more drug components, thereby realizing better treatment effect; meanwhile, a user can select any one, any two or three of the three physical auxiliary means through the remote controller 20, so that the compatibility is strong, the practicability is high, and the electrode tip 50 can be used for more accurately treating different disease causes; therefore, the problems that the traditional medicine guide instrument in the prior art does not have a physical auxiliary means to promote the skin of a user to absorb medicines, the traditional medicine guide instrument is poor in treatment effect on the part of the human body subjected to physical therapy, and the use experience of the user is low are effectively solved.
Specifically, the signal conversion module 40 includes an ultrasonic wave generation module 401, wherein the ultrasonic wave generation module 401 is connected to the single chip microcomputer module 30, the ultrasonic wave generation module 401 accesses the control signal D2, and the ultrasonic wave generation module 401 generates a first drug guide signal D3 according to the control signal D2, and the first drug guide signal D3 generated by the ultrasonic wave generation module 401 has a specific frequency and amplitude; as an alternative implementation, fig. 2 shows a circuit structure of an ultrasonic wave generating module 401 provided in an embodiment of the present invention, and as shown in fig. 2, the ultrasonic wave generating module 401 includes: the circuit comprises a first PNP triode Q1, a first NPN triode Q2, a second NPN triode Q3, a first resistor R1, a second resistor R2, a third resistor R3, a fourth resistor R4, a fifth resistor R5, a sixth resistor R6, a seventh resistor R7, a first capacitor C1, a second capacitor C2, a third capacitor C3, a fourth capacitor C4, a fifth capacitor C5, a sixth capacitor C6, a seventh capacitor C7, an eighth capacitor C8, a ninth capacitor C9, a tenth capacitor C10, a first inductor L1, a second inductor L2, a third inductor L3, a first connector CH1 and a second connector CH 2.
Wherein, the emitter of the first PNP triode Q1 is connected to a first dc power supply, illustratively, the first dc power supply is a-5V power supply; the base electrode of the first PNP type triode Q1 is connected with the first end of the first resistor R1, the second end of the first resistor R1 is connected with the remote controller 20 and used for accessing the key signal D1; a first end of the second resistor R2 and a first end of the third resistor R3 are commonly connected to a collector of the first PNP transistor Q1, a second end of the second resistor R2 and a first end of the first capacitor C1 are connected to a first end of the first inductor L1, a second end of the first capacitor C1 is grounded GND, a second end of the third resistor R3 and a first end of the sixth capacitor C6 are commonly connected to a first end of the second inductor L2, a second end of the sixth capacitor C6 is grounded GND, a first end of the second capacitor C2, a first end of the fourth resistor R4 and a first end of the third capacitor C3 are commonly connected to a second end of the first inductor L1, a second end of the third capacitor C3 is connected to a first input end of the first connector CH1, a first end of the fourth capacitor C4, a collector of the first NPN transistor Q2, a first end of the fifth capacitor C5, and a second input end of the first connector CH1 are commonly connected to a second dc power supply, which is illustratively a-50V power supply; the output end of the first connector CH1 outputs a first medicine guiding signal D3, the second end of the fourth resistor R4 and the second end of the fourth capacitor C4 are commonly connected to the base of the first NPN transistor Q2, the second end of the second capacitor C2, the emitter of the first NPN transistor Q2, and the second end of the fifth capacitor C5 are commonly connected to the first end of the third inductor L3, the second end of the third inductor L3 is connected to the first end of the sixth resistor R6, and the second end of the sixth resistor R6 is grounded GND.
The first end of the seventh capacitor C7, the first end of the eighth capacitor C8, and the first end of the fifth resistor R5 are commonly connected to the second end of the second inductor L2, the second end of the seventh capacitor C7 is connected to the first input end of the second connector CH2, the first end of the ninth capacitor C9, the collector of the second NPN transistor Q3, the first end of the tenth capacitor C10, and the second input end of the second connector CH2 are commonly connected to the second dc power supply, as described above, in this embodiment, the second dc power supply is a-50V power supply; a second end of the fifth resistor R5 and a second end of the ninth capacitor C9 are commonly connected to the base of the second NPN transistor Q1, a second end of the eighth capacitor C8, an emitter of the second NPN transistor Q3, and a second end of the tenth capacitor C10 are commonly connected to a first end of the fourth inductor L4, a second end of the fourth inductor L4 is connected to a first end of the seventh resistor R7, and a second end of the seventh resistor R7 is grounded GND.
In the circuit structure of the ultrasonic wave generating module 401, the first connector CH1 and the second connector CH2 are used as signal transfer devices, when a plurality of input ends of the connectors (including the first connector CH1 and the second connector CH2) are respectively connected with signals, the connectors can intensively process and transmit the signals, and then the output end of the first connector CH1 and the output end of the second connector CH2 can output a first medicine guide signal D3; therefore, the ultrasonic wave generating module 401 shown in fig. 2 has a simpler circuit structure, and is easy to implement, when the second end of the first resistor R1 is connected to the key signal D1, the key signal D1 can control the first PNP transistor Q1 to be turned on or off, and further, when the first NPN transistor Q2 and the second NPN transistor Q3 are in different on or off states, respectively, so that the electrode tip 50 can be driven by the first drug-guiding signal D3 output by the signal converting module 401 to implement the function of guiding the drug by the ultrasonic wave.
As a specific implementation manner, the signal conversion module 40 includes an electrical pore generation module 402, the electrical pore generation module 402 is connected to the single chip microcomputer module 30, the single chip microcomputer module 30 transmits the control signal D2 to the electrical pore generation module 402, the electrical pore generation module 402 generates a second drug guiding signal D4 according to the control signal D2, wherein the amplitude of the second drug guiding signal D4 can be adjusted according to the needs of a user, and when the electrical pore generation module 402 transmits the second drug guiding signal D4 to the electrode tip 50, the electrode tip 50 can electrically conduct pore generation and drug guiding on a human body according to the second drug guiding signal D4, thereby achieving an optimal therapeutic effect; specifically, fig. 3 shows a module structure of the electrical pore generation module 402 provided in the embodiment of the present invention, and as shown in fig. 3, the electrical pore generation module 402 includes: a first voltage conversion unit 4021, a second voltage conversion unit 4022, a third voltage conversion unit 4023, and a fourth voltage conversion unit 4024; the first voltage conversion unit 4021 converts the third dc power V3 and the battery power BAT1 into a first voltage signal D41 and a second voltage signal D42; the second voltage conversion unit 4022 converts the battery power BAT1 into a third voltage signal D43; the third voltage conversion unit 4023 is connected to the first voltage conversion unit 4021, the first voltage conversion unit 4021 transmits the first voltage signal D41 to the third voltage conversion unit 4023, and the third voltage conversion unit 4023 converts the first voltage signal D41 into a fourth voltage signal D44; the fourth voltage conversion unit 4024 is connected to the third voltage conversion unit 4023 and the single chip module 30, and the fourth voltage conversion unit 4024 converts the fourth voltage signal D44 into the fifth voltage signal D45 according to the control signal D2.
It should be noted that, in the module structure of the electrical pore generation module 402 shown in fig. 3, each of the voltage conversion units (the first voltage conversion unit 4021, the second voltage conversion unit 4022, the third voltage conversion unit 4023, and the fourth voltage conversion unit 4024) in the electrical pore generation module 402 outputs five voltage signals (including a first voltage signal D41, a second voltage signal D42, a third voltage signal D43, a fourth voltage signal D44, and a fifth voltage signal D45), where the five voltage signals constitute a second drug guiding signal D4; optionally, the amplitudes of the five voltage signals may be the same or different, and are not limited thereto, in the embodiment of the present invention, the amplitudes of the five voltage signals are different, for example, the amplitude of the first voltage signal D41 is-20V, the amplitude of the second voltage signal D42 is-12V, the amplitude of the third voltage signal D43 is-5V, the amplitude of the fourth voltage signal D44 is-50V, and the amplitude of the fifth voltage signal D45 is-100V; as described above, when the second guiding signal D4 has different amplitudes, the electrode tip 50 can achieve different electroporation guiding effects according to the second guiding signal D4; therefore, in the electrical pore-forming generation module 402 provided in the embodiment of the present invention, the second drug-guiding signal D4 includes five voltage signals, and the electrode tip 50 can achieve different electrical pore-forming drug-guiding effects on the receiving treatment site of the human body according to the second drug-guiding signal D4, so as to achieve the optimal drug treatment effect for various diseases.
As an alternative implementation, fig. 4 shows a circuit structure of the first voltage conversion unit 4021 provided IN an embodiment of the present invention, and as shown IN fig. 4, the first voltage conversion unit 4021 includes an electronic device such as a boost chip, a diode, a resistor, and a capacitor, IN an embodiment of the present invention, the model of the boost chip is MT3608, when the third dc power supply V3 and the battery power supply BAT1 transmit voltages to the voltage input pins IN and EN of the boost chip, the boost chip has a function of boosting and stabilizing the input voltage, the signal output pin SW of the boost chip outputs a voltage regulation signal, and further the first voltage conversion unit 4021 can output the first voltage signal D41 and the second voltage signal D42.
As an optional implementation, fig. 5 shows a circuit structure of the second voltage conversion unit 4022 provided in this embodiment of the present invention, and as shown in fig. 5, the second voltage conversion unit 4022 includes a buck chip, a resistor, an inductor, and electronic components such as a diode, optionally, the model of the buck chip is AX3007C-ADJ, and the buck chip has functions of reducing and stabilizing voltage, where a voltage input pin VIN of the buck chip is connected to the battery power supply BAT1, the buck chip converts the input voltage, a voltage output pin VOUT of the buck chip outputs the voltage after voltage reduction, and the second voltage conversion unit 4022 can output the third voltage signal D43.
As an alternative implementation, fig. 6 shows a circuit structure of a third voltage conversion unit 4023 provided in an embodiment of the present invention, as shown in fig. 6, the third voltage conversion unit 4023 includes electronic components such as a voltage conversion chip, a resistor, and a capacitor, wherein the model of the voltage conversion chip is TPS28225, wherein a driving signal input pin Driver-C of the voltage conversion chip is connected with a driving signal, a voltage input pin VCC of the voltage conversion chip is connected with a first voltage signal D41, the voltage conversion chip converts the first voltage signal D41 under the driving of the driving signal, the converted voltage signal is output through the voltage output pin Switch-C of the voltage conversion chip, i.e., the fourth voltage signal D44, so that in the circuit configuration of the third voltage converting unit 4023, the function of converting the first voltage signal D41 into the fourth voltage signal D44 is realized by a voltage conversion chip.
As an alternative implementation, fig. 7 shows a circuit structure of a fourth voltage conversion unit 4024 provided in an embodiment of the present invention, and as shown in fig. 7, the fourth voltage conversion unit 4024 includes: the base of the NPN-type triode Q701 is connected to the control signal D2 through the resistor R701, the NPN-type triode Q701, the PNP-type triode Q702 and the NPN-type triode Q703 are controlled to be turned on or off through the control signal D2, and the electronic component in the fourth voltage conversion unit 4024 converts the fourth voltage signal D44 into a fifth voltage signal D45; therefore, the fourth voltage conversion unit 4024 realizes a function of converting between different voltage signals.
With reference to the specific circuit structure diagrams of the four voltage converting units (the first voltage converting unit 4021, the second voltage converting unit 4022, the third voltage converting unit 4023, and the fourth voltage converting unit 4024) shown in fig. 4-7, when the signal converting module 40 accesses the control signal D2, the four voltage converting units may obtain the first voltage signal D41, the second voltage signal D42, the third voltage signal D43, the fourth voltage signal D44, and the fifth voltage signal D45, since the five voltage signals have specific amplitudes, when the signal converting module 40 respectively transmits the five voltage signals to the electrode tip 50, the electrode tip 50 electrically conducts electrical pore-forming drug introduction to a human body according to the five voltage signals; and the electrode tip 50 respectively realizes the electric pore-forming drug guiding with different amplitudes under the driving of the five voltage signals, so that the receiving treatment part of the human body can absorb the most drug components, and the ultrasonic intermediate frequency drug guiding instrument 10 can generate the best treatment effect on the receiving treatment part of the human body.
As a specific implementation manner, the signal conversion module 40 includes an intermediate-frequency electric pulse generation module 403, where the intermediate-frequency electric pulse generation module 403 is connected to the single chip microcomputer module 30, and when the signal conversion module 40 accesses the control signal D2, the intermediate-frequency electric pulse generation module 403 generates a third drug delivery signal D5 according to the control signal D2, where the third drug delivery signal D5 generated by the intermediate-frequency electric pulse generation module 403 has a specific frequency, and when the third drug delivery signal D5 is transmitted to the electrode tip 50, the electrode tip 50 can implement a function of delivering drugs according to the third drug delivery signal D5; specifically, fig. 8 shows a circuit structure of the intermediate-frequency electric pulse generation module 403 according to an embodiment of the present invention, fig. 9 shows a module structure of the intermediate-frequency electric pulse generation module 403 according to an embodiment of the present invention, and with reference to fig. 8 and 9, the intermediate-frequency electric pulse generation module 403 includes a signal receiving unit 4031, a signal generation unit 4032, and a signal output unit 4033, where the signal receiving unit 4031 is connected to the single chip microcomputer module 30, the signal receiving unit 4031 receives the control signal D2, and as shown in fig. 8, the signal receiving unit 4031 includes a plurality of electronic components such as resistors, and the signal receiving unit 4031 can perform functions of signal transmission and transmission; the signal generating unit 4032 is connected to the signal receiving unit 4031, the signal receiving unit 4031 transmits the control signal D2 to the signal generating unit 4032, and the signal generating unit 4032 converts the dc power signal VCC according to the control signal D2 to obtain a third medicine guiding signal D5; as shown in fig. 8, a specific circuit configuration of the signal generating unit 4032 is provided in the signal generating unit 4032, which includes: when the signal generating unit 4032 is connected to the control signal D2, the operational amplifier amplifies an input power, and the MOS transistor and the triode are driven by the control signal D2 to be turned on and off, so that the signal generating unit 4032 can convert the dc power signal VCC to obtain a third medicine guide signal D5, where it should be noted that the dc power signal VCC includes the components shown in fig. 8: a dc power supply V4, a dc power supply V5, a dc power supply V6, a dc power supply V7, and a dc power supply V8; the signal output unit 4033 is connected to the signal generation unit 4032, the signal generation unit 4032 transmits the third drug delivery signal D5 to the signal output unit 4033, the signal output unit 4033 outputs the third drug delivery signal D5 to the electrode tip 50, so that the electrode tip 50 conducts intermediate-frequency electric pulse drug delivery to a human body according to the third drug delivery signal D5, and according to the circuit structure of the signal output unit 4033 shown in fig. 8, the signal output unit 4033 includes electronic components such as a double-pole switch, a triode, a capacitor, and the like, so that the signal output unit 4033 implements: the third drug delivery signal D5 is rapidly transmitted between the intermediate frequency electric pulse generation module 403 and the electrode tip 50.
As a preferred implementation manner, fig. 10 shows another module structure of the ultrasound intermediate frequency drug guide apparatus 10 provided in the embodiment of the present invention, and compared with the ultrasound intermediate frequency drug guide apparatus 10 shown in fig. 1, the ultrasound intermediate frequency drug guide apparatus 10 shown in fig. 10 further includes: an optical alarm module 1011, an electric quantity detection module 1012 and an acousto-optic prompt module 1015; the optical alarm module 1011 is connected to the electroporation generating module 402, the optical alarm module 1011 detects an operating voltage in the electroporation generating module 402, and sends an alarm signal when the operating voltage in the electroporation generating module 402 is greater than a preset voltage; as described above, when the second drug guiding signal D4 is generated by the electroporation generating module 402, if the operating voltage in the electroporation generating module 402 changes, the amplitude of the second drug guiding signal D4 also changes accordingly, and at this time, the electrode tip 50 can achieve different electroporation drug guiding effects on the receiving treatment site of the human body according to the third drug guiding signal D5; however, in the process of performing the electrical pore-forming drug-guiding operation on the human body by the ultrasonic drug-guiding instrument 10, if the operating voltage in the electrical pore-forming generation module 402 is too large, the electrode tip 50 will generate too strong electrical stimulation to the skin of the human body, which not only reduces the ability of the skin to absorb the drug components, but also damages the normal skin tissue of the human body by the larger electrical stimulation; therefore, the light alarm module 1011 detects the operating voltage in the electrical pore generation module 402 in real time, and immediately sends out an alarm signal if the operating voltage in the electrical pore generation module 402 is greater than the preset voltage, and the alarm signal is used for sending out warning information to a user: the operating voltage in the electrical pore generation module 402 is too high, and the operating voltage in the electrical pore generation module 402 needs to be reduced in time; it should be noted that the preset voltage is set in advance, for example, a technician may set the preset voltage according to a specific circuit structure of the electroporation generating module 402.
As an optional implementation manner, fig. 11 shows a circuit structure of an optical alarm module 1011 according to an embodiment of the present invention, as shown in fig. 11, the optical alarm module 1011 includes electronic components such as a comparator, an NPN type triode, a resistor, a capacitor, a voltage comparator chip, and an LED (Light Emitting Diode) lamp, where the type of the voltage comparator chip includes, but is not limited to, LM339 or LM 331; the light alarm module 1011 detects the operating voltage VCC2 in the electrical pore generation module 402 in real time, and when the light alarm module 1011 detects that the operating voltage VCC2 in the electrical pore generation module 402 is greater than the preset voltage VCC1, the signal output pin OUT of the voltage comparator chip outputs an LED on signal, and at this time, the LED lamp sends OUT an alarm signal according to the LED on signal, so as to send OUT warning information to a user.
As a specific implementation manner, the electric quantity detection module 1012 is connected to the single chip microcomputer module 30, and the electric quantity of the single chip microcomputer module 30 can be detected in real time through the electric quantity detection module 1012; as described above, the single chip microcomputer module 30 has processing and converting functions for signals, so that the electric quantity condition of the single chip microcomputer module 30 can be monitored in real time through the electric quantity detection module 1012, and the situation that the ultrasonic intermediate frequency medicine guide instrument 10 cannot normally work due to insufficient electric energy of the single chip microcomputer module 30 is avoided; as an alternative implementation, fig. 12 shows a circuit structure of the power detection module 1012 according to an embodiment of the present invention, and as shown in fig. 12, the power detection module 1012 includes: the ultrasonic medium-frequency medicine guide instrument comprises electronic components such as a resistor, a capacitor and an operational amplifier, wherein the output end of the operational amplifier OP1 is connected with the single chip microcomputer module 30, and then the electric quantity condition of the single chip microcomputer module 1012 is detected through the electric quantity detection module 1012, so that the ultrasonic medium-frequency medicine guide instrument 10 can be in a normal working state.
As a specific implementation manner, the acousto-optic prompt module 1015 is connected to the single chip module 30, and detects whether the single chip module 30 is in a working state through the acousto-optic prompt module 1015, and when the single chip module 30 is in the working state, the acousto-optic prompt module 1015 sends an acousto-optic prompt signal; as described above, since the single chip module 30 has the functions of signal processing and signal conversion in the ultrasonic intermediate frequency drug guide apparatus 10, it can be determined that the ultrasonic intermediate frequency drug guide apparatus 10 is in the working state or the stop state by detecting that the single chip module 30 is in the working state or the stop state; further, when single chip module 30 is in operating condition, reputation suggestion module 1015 sends reputation cue signal, and the user can know the operating condition of supersound intermediate frequency medicine guide instrument 10 according to reputation cue signal directly perceivedly to the user is using this supersound intermediate frequency medicine guide instrument 10 to lead the medicine in-process, and the user can learn supersound intermediate frequency medicine guide instrument 10 operating condition at any time, brings good use experience for the user and feels.
As an alternative embodiment, the audible and visual prompting module 1015 includes a first prompting module 1013 and a second prompting module 1014, wherein the first prompting module 1013 detects whether the single chip microcomputer module 30 is in an operating state, and when the single chip microcomputer module 30 is in the operating state, the first prompting module 1013 emits an audible prompting signal; the second prompting module 1014 is connected with the single chip microcomputer module 30, the second prompting module 1014 detects whether the single chip microcomputer module 30 is in a working state, and when the single chip microcomputer module 30 is in the working state, the second prompting module 1014 emits an optical prompting signal, and the optical prompting signal and the acoustic prompting signal form an acoustic prompting signal; fig. 13 shows a circuit structure of the first prompting module 1013 according to the embodiment of the present invention, as shown in fig. 13, the first prompting module 1013 includes electronic components such as a resistor, an NPN type triode, a diode, and a speaker, where a gate of the NPN type triode Q130 is connected to the chip module 30 through the resistor R131, and a sound prompting signal is sent through the speaker LS130 to remind a user that the ultrasonic if guide apparatus 10 is in a working stage at this time.
As an optional implementation manner, fig. 14 shows a circuit structure of the second prompting module 1014 according to an embodiment of the present invention, as shown in fig. 14, the second prompting module 1014 includes electronic components such as a resistor, a light emitting diode, and an NPN-type triode, where a base of the triode is connected to the single chip microcomputer module 30 through the resistor R140, and when the single chip microcomputer module 30 is in an operating state, the light emitting diode LED2 emits a light prompting signal, so that a user can know an operating state of the ultrasonic intermediate frequency medicine guide apparatus 10 in real time according to the light prompting signal.
As an optional implementation manner, fig. 15 shows a circuit structure of the single chip module 30 provided in the embodiment of the present invention, as shown in fig. 15, the single chip module 30 includes a single chip, and optionally, the type of the single chip is STC15F2K60S2, where a pin of the single chip is externally connected to an electronic component, a signal receiving pin of the single chip is connected to a remote controller, and is used for accessing a key signal D1, and according to the single chip shown in fig. 15, the signal receiving pin of the single chip includes: AD5/P0.5, AD7/P0.7, PxD2/CCP1/ADCOP1.0, SCLK/ADC 5/P1.5; the signal output pin of the single chip is connected to the signal conversion module 10, and is used for transmitting the control signal D2 to the signal conversion module 10, and the signal output pin of the single chip includes: P2.3/A11/MOSI _2, P2.2/A10/MISO _2, P2.1/A9/SCLK _2, P2.0/A8/RSTOUT _ LOW, P4.3/SCLK _3, P3.7/INT3/TxD _2/CCP2/CCP2_2, P3.6/INT2/RxD _2/CCP1_2, P3.5/T1/TOCLCO/CCPO _2, P3.4/T0/T1CLKO/ECL2, P3.3/INT1 and P3.2/INT 0; therefore, in the single chip module 30, the functions of processing and converting signals can be realized through the single chip.
According to the circuit structure of the ultrasonic intermediate frequency medicine guide instrument 10, a user can select different medicine guide functions through the remote controller 20, when the single chip microcomputer module 30 transmits the control signal D2 to the signal conversion module 40, the signal conversion module 40 can generate three medicine guide signals (a first medicine guide signal D3, a second medicine guide signal D4 and a third medicine guide signal D5) according to the control signal D2, so that ultrasonic medicine guide, electric pore medicine guide and intermediate frequency electric pulse medicine guide can be respectively carried out on physical therapy parts of a human body according to the three medicine guide signals through the electrode tip 50; therefore, the ultrasonic intermediate frequency medicine guide instrument in the embodiment of the invention adopts three physical auxiliary means to enhance the medicine absorption capacity of human skin, has strong compatibility and improves the curative effect of the medicine on the human body receiving and treating part; the problem that the traditional medicine guide instrument lacks physical auxiliary means to promote the skin of a user to absorb medicines, and further the treatment effect of the medicine guide instrument on the part of the human body subjected to physical therapy is poor is effectively solved.
It should be noted that, in this document, such as a plurality and a plurality, each means a number greater than 1; relational terms such as first and second, and the like may be used solely to distinguish one entity from another entity without necessarily requiring or implying any actual such relationship or order between such entities. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a product or structure that comprises a list of elements is inherently related to the elements. Without further limitation, an element defined by the phrases "comprising … …" or "comprising … …" does not exclude the presence of additional elements in a process, method, article, or terminal that comprises the element. Further, herein, "greater than," "less than," "more than," and the like are understood to exclude the present numbers; the terms "above", "below", "within" and the like are to be understood as including the number.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
Claims (10)
1. An ultrasonic intermediate frequency medicine guide instrument is characterized by comprising:
a remote controller configured to acquire a key signal of a user;
the singlechip module is connected with the remote controller and generates a control signal according to the key signal;
the signal conversion module is connected with the single chip microcomputer module and is configured to generate at least one of a first medicine guide signal, a second medicine guide signal and a third medicine guide signal according to the control signal;
the electrode tip is connected with the signal conversion module and is configured to conduct ultrasonic medicine guiding according to the first medicine guiding signal, conduct electric pore-forming medicine guiding according to the second medicine guiding signal and conduct medium-frequency electric pulse medicine guiding according to the third medicine guiding signal.
2. The ultrasonic intermediate-frequency drug delivery instrument according to claim 1, wherein the electrode tip comprises a first electrode tip and a second electrode tip.
3. The ultrasonic intermediate frequency drug guide instrument according to claim 1, wherein the signal conversion module comprises:
and the ultrasonic generation module is connected with the singlechip module, is configured to access the control signal and generates the first medicine guide signal according to the control signal.
4. The ultrasonic intermediate-frequency drug guide instrument according to claim 3, wherein the ultrasonic wave generation module comprises: the first PNP type triode, the first NPN type triode, the second NPN type triode, the first resistor, the second resistor, the third resistor, the fourth resistor, the fifth resistor, the sixth resistor, the seventh resistor, the first capacitor, the second capacitor, the third capacitor, the fourth capacitor, the fifth capacitor, the sixth capacitor, the seventh capacitor, the eighth capacitor, the ninth capacitor, the tenth capacitor, the first inductor, the second inductor, the third inductor, the first connector and the second connector;
wherein, the emitter of the first PNP triode is connected to the first dc power supply, the base of the first PNP triode is connected to the first end of the first resistor, the second end of the first resistor is connected to the remote controller, the first end of the second resistor and the first end of the third resistor are connected to the collector of the first PNP triode, the second end of the second resistor and the first end of the first capacitor are connected to the first end of the first inductor, the second end of the first capacitor is grounded, the second end of the third resistor and the first end of the sixth capacitor are connected to the first end of the second inductor, the second end of the sixth capacitor is grounded, the first end of the second capacitor, the first end of the fourth resistor and the first end of the third capacitor are connected to the second end of the first inductor, the second end of the third capacitor is connected to the first input end of the first connector, a first end of the fourth capacitor, a collector of the first NPN-type triode, a first end of the fifth capacitor, and a second input end of the first connector are all connected to a second direct-current power supply, an output end of the first connector is used for outputting the first medicine guiding signal, a second end of the fourth resistor and a second end of the fourth capacitor are all connected to a base of the first NPN-type triode, a second end of the second capacitor, an emitter of the first NPN-type triode, and a second end of the fifth capacitor are all connected to a first end of the third inductor, a second end of the third inductor is connected to a first end of the sixth resistor, and a second end of the sixth resistor is grounded;
the first end of the seventh capacitor, the first end of the eighth capacitor and the first end of the fifth resistor are connected to the second end of the second inductor in common, a second end of the seventh capacitor is connected to the first input end of the second connector, a first end of the ninth capacitor, a collector of the second NPN transistor, a first end of the tenth capacitor, and a second input end of the second connector are commonly connected to the second dc power supply, a second end of the fifth resistor and a second end of the ninth capacitor are commonly connected to the base of the second NPN transistor, a second end of the eighth capacitor, an emitter of the second NPN transistor, and a second end of the tenth capacitor are connected to the first end of the fourth inductor, the second end of the fourth inductor is connected with the first end of the seventh resistor, and the second end of the seventh resistor is grounded.
5. The ultrasonic intermediate frequency drug guide instrument according to claim 1, wherein the signal conversion module comprises:
and the electric pore-forming generation module is connected with the singlechip module and is configured to generate the second medicine guide signal according to the control signal.
6. The ultrasonic intermediate-frequency drug guide instrument according to claim 5, wherein the electroporation generating module comprises:
a first voltage conversion unit configured to convert the third direct current power supply and the battery power supply into a first voltage signal and a second voltage signal;
a second voltage conversion unit configured to convert the battery power source into a third voltage signal;
a third voltage conversion unit connected to the first voltage conversion unit and configured to convert the first voltage signal into a fourth voltage signal;
and the fourth voltage conversion unit is connected with the third voltage conversion unit and the singlechip module and is configured to convert the fourth voltage signal into a fifth voltage signal according to the control signal.
7. The ultrasonic mid-frequency drug guide instrument according to claim 5, further comprising:
and the light alarm module is connected with the electric pore generation module and is configured to detect the operating voltage in the electric pore generation module and send out an alarm signal when the operating voltage in the electric pore generation module is greater than a preset voltage.
8. The ultrasonic mid-frequency drug guide instrument according to claim 1, further comprising:
and the acousto-optic prompting module is connected with the singlechip module and is configured to detect whether the singlechip module is in a working state or not, and emits an acousto-optic prompting signal when the singlechip module is in the working state.
9. The ultrasonic intermediate frequency drug guide instrument according to claim 1, wherein the signal conversion module comprises:
and the intermediate frequency electric pulse generation module is connected with the singlechip module and is configured to access the control signal and generate the third medicine guide signal according to the control signal.
10. The ultrasonic mid-frequency drug guide instrument as claimed in claim 9, wherein the mid-frequency electric pulse generation module comprises:
the signal receiving unit is connected with the singlechip module and is configured to receive the control signal;
the signal generating unit is connected with the signal receiving unit and is configured to convert a direct-current power supply signal according to the control signal to obtain a third medicine guide signal;
and the signal output unit is connected with the signal generation unit and is configured to output the third medicine guide signal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810618640.7A CN110604867B (en) | 2018-06-15 | 2018-06-15 | Ultrasonic medium-frequency medicine guiding instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810618640.7A CN110604867B (en) | 2018-06-15 | 2018-06-15 | Ultrasonic medium-frequency medicine guiding instrument |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110604867A true CN110604867A (en) | 2019-12-24 |
| CN110604867B CN110604867B (en) | 2024-08-02 |
Family
ID=68888091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810618640.7A Active CN110604867B (en) | 2018-06-15 | 2018-06-15 | Ultrasonic medium-frequency medicine guiding instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110604867B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112933389A (en) * | 2020-11-05 | 2021-06-11 | 沈阳中康医疗科技有限公司 | Portable ultrasonic direct current electric pulse iontophoresis therapeutic instrument |
Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5415629A (en) * | 1993-09-15 | 1995-05-16 | Henley; Julian L. | Programmable apparatus for the transdermal delivery of drugs and method |
| WO1998029134A2 (en) * | 1996-12-31 | 1998-07-09 | Altea Technologies, Inc. | Microporation of tissue for delivery of bioactive agents |
| KR200170785Y1 (en) * | 1999-08-31 | 2000-03-15 | 주식회사비바리 | A device for treating the skin trouble |
| WO2004110206A1 (en) * | 2003-06-17 | 2004-12-23 | Hwang, Seung-Young | Ultrasonic vibrator having ion-transmission function and skin care apparatus using the same |
| WO2007028114A2 (en) * | 2005-09-02 | 2007-03-08 | Encapsulation Systems, Inc. | Wound treatment method and system |
| CN102149429A (en) * | 2008-07-10 | 2011-08-10 | 康奈尔大学 | Ultrasound wave generating apparatus |
| CN102500047A (en) * | 2011-10-03 | 2012-06-20 | 缪长莉 | Multifunctional ultrasonic beautifier |
| CN102895744A (en) * | 2012-10-29 | 2013-01-30 | 汕头市创新科技电子有限公司 | Ultrasonic beautifying instrument |
| CN202892654U (en) * | 2012-10-30 | 2013-04-24 | 沈阳中康世创科技有限公司 | Percutaneous drug-leading in instrument signal generating circuit |
| CN103785103A (en) * | 2012-10-30 | 2014-05-14 | 沈阳中康世创科技有限公司 | Signal generation circuit for percutaneous medicine leading-in instrument |
| JP2015116383A (en) * | 2013-12-19 | 2015-06-25 | 株式会社テクノリンク | Ultrasonic living body stimulation device |
| CN105771081A (en) * | 2016-03-29 | 2016-07-20 | 北京中美联医学科学研究院有限公司 | Ultrasonic conductivity meter and ultrasonic delivery method thereof |
| CN205698888U (en) * | 2016-03-29 | 2016-11-23 | 北京中美联医学科学研究院有限公司 | A kind of ultrasonic conductivity meter |
| CN206454114U (en) * | 2016-07-29 | 2017-09-01 | 沈阳市美辰医疗器械有限公司 | A kind of Ultrasonic-intermediate Frequency leads medicine instrument |
| CN107320842A (en) * | 2017-08-14 | 2017-11-07 | 长春市罡恒电子有限责任公司 | Low frequency ultrasound leads medicine instrument |
| CN209952046U (en) * | 2018-06-15 | 2020-01-17 | 博健通大健康(深圳)有限公司 | Control circuit of ultrasonic intermediate frequency medicine guide instrument |
-
2018
- 2018-06-15 CN CN201810618640.7A patent/CN110604867B/en active Active
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5415629A (en) * | 1993-09-15 | 1995-05-16 | Henley; Julian L. | Programmable apparatus for the transdermal delivery of drugs and method |
| WO1998029134A2 (en) * | 1996-12-31 | 1998-07-09 | Altea Technologies, Inc. | Microporation of tissue for delivery of bioactive agents |
| KR200170785Y1 (en) * | 1999-08-31 | 2000-03-15 | 주식회사비바리 | A device for treating the skin trouble |
| WO2004110206A1 (en) * | 2003-06-17 | 2004-12-23 | Hwang, Seung-Young | Ultrasonic vibrator having ion-transmission function and skin care apparatus using the same |
| WO2007028114A2 (en) * | 2005-09-02 | 2007-03-08 | Encapsulation Systems, Inc. | Wound treatment method and system |
| CN102149429A (en) * | 2008-07-10 | 2011-08-10 | 康奈尔大学 | Ultrasound wave generating apparatus |
| CN102500047A (en) * | 2011-10-03 | 2012-06-20 | 缪长莉 | Multifunctional ultrasonic beautifier |
| CN102895744A (en) * | 2012-10-29 | 2013-01-30 | 汕头市创新科技电子有限公司 | Ultrasonic beautifying instrument |
| CN202892654U (en) * | 2012-10-30 | 2013-04-24 | 沈阳中康世创科技有限公司 | Percutaneous drug-leading in instrument signal generating circuit |
| CN103785103A (en) * | 2012-10-30 | 2014-05-14 | 沈阳中康世创科技有限公司 | Signal generation circuit for percutaneous medicine leading-in instrument |
| JP2015116383A (en) * | 2013-12-19 | 2015-06-25 | 株式会社テクノリンク | Ultrasonic living body stimulation device |
| CN105771081A (en) * | 2016-03-29 | 2016-07-20 | 北京中美联医学科学研究院有限公司 | Ultrasonic conductivity meter and ultrasonic delivery method thereof |
| CN205698888U (en) * | 2016-03-29 | 2016-11-23 | 北京中美联医学科学研究院有限公司 | A kind of ultrasonic conductivity meter |
| CN206454114U (en) * | 2016-07-29 | 2017-09-01 | 沈阳市美辰医疗器械有限公司 | A kind of Ultrasonic-intermediate Frequency leads medicine instrument |
| CN107320842A (en) * | 2017-08-14 | 2017-11-07 | 长春市罡恒电子有限责任公司 | Low frequency ultrasound leads medicine instrument |
| CN209952046U (en) * | 2018-06-15 | 2020-01-17 | 博健通大健康(深圳)有限公司 | Control circuit of ultrasonic intermediate frequency medicine guide instrument |
Non-Patent Citations (1)
| Title |
|---|
| 雷志球，王芹芹，瞿少成，李玉海: "透皮给药医疗仪器高精度脉冲电路设计与实现", 《电子测量技术》, vol. 35, no. 4, 30 April 2012 (2012-04-30) * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112933389A (en) * | 2020-11-05 | 2021-06-11 | 沈阳中康医疗科技有限公司 | Portable ultrasonic direct current electric pulse iontophoresis therapeutic instrument |
| CN112933389B (en) * | 2020-11-05 | 2022-11-01 | 沈阳中康医疗科技有限公司 | Portable ultrasonic direct current electric pulse iontophoresis therapeutic instrument |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110604867B (en) | 2024-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9764133B2 (en) | Portable TENS apparatus and method of use thereof | |
| US8630714B1 (en) | Bone growth stimulation using a constant current capacitively coupled stimulator | |
| CN106345057B (en) | A kind of electroacupuncture stimulation intelligence body shaping underwear system | |
| CN206792806U (en) | A kind of low frequency transcutaneous stimulation instrument of multi-channel multi-parameter bipolarity constant current | |
| US20230414973A1 (en) | Systems and Methods Using Ultrasound for Treatment | |
| KR102089634B1 (en) | Smartphone Interface Device for Low Level Light Therapy | |
| CN103300853B (en) | Diagnosis and treatment system based on surface myoelectricity | |
| TW201231039A (en) | Handheld cell excitation terminal capable of dynamic optimization of therapeutic effect and remote therapeutic system | |
| AU2013207901B2 (en) | Portable TENS apparatus and method of use thereof | |
| CA2974595A1 (en) | Systems and methods using ultrasound for treatment | |
| CN111939068A (en) | A kind of myoelectric feedback intelligent acupuncture physiotherapy instrument | |
| CN106110500A (en) | A treatment device and its control method | |
| CN209952046U (en) | Control circuit of ultrasonic intermediate frequency medicine guide instrument | |
| CN111317558A (en) | Tumor ablation equipment using ultrahigh-voltage positive-negative composite pulse electric field | |
| CN110604867B (en) | Ultrasonic medium-frequency medicine guiding instrument | |
| CN111228649B (en) | Low-temperature plasma generating device with adjustable strength | |
| CN105536143A (en) | Remote-control electronic acupuncture and moxibustion device | |
| CN201445703U (en) | Audio frequency modulation electrotherapy instrument based on doctor's workstation | |
| CN103986444B (en) | A kind of physical agent output control method and device | |
| CN109876296A (en) | A kind of electrical acupuncture therapeutic equipment | |
| CN111450413B (en) | Cerebral apoplexy patient sense of touch rehabilitation system | |
| CN113101520A (en) | Electrical stimulation bladder therapy system based on intelligent control terminal | |
| CN107007933B (en) | Pace-making generating device | |
| KR20160089286A (en) | Microcurrent stimulator using an earphone socket of mobile terminal and thereof method | |
| CN210044701U (en) | Electronic acupuncture therapeutic instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20240621 Address after: 518000 Building B4201, Building 18, Junfeng Industrial Park, Chongqing Road, Heping Community, Fuhai Street, Bao'an District, Shenzhen City, Guangdong Province Applicant after: Haichuang Medical Technology (Shenzhen) Co.,Ltd. Country or region after: China Address before: 518000 East Area, 6th Floor, Zhonggang Building, Building M-7, Maqueling Industrial Zone, Gaoxin Middle Zone, Nanshan District, Shenzhen, Guangdong Province Applicant before: BOJIANTONGDA ENLARGED CONCEPT OF HEALTH (SHENZHEN) Co.,Ltd. Country or region before: China |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |